Risk-Benefit Events Associated with the Use of Aspirin for Primary Prevention of Cardiovascular Disorders
Aspirin had been introduced as a nonsteroidal anti-inflammatory molecule. As further research on aspirin started, other therapeutic effects have been revealed. Now, this molecule has become the polychrest in medical science. Aspirin has served as a drug of choice for the primary prevention of cardio...
Guardado en:
| Autores principales: | , , , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2020
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/72930 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Risk-Benefit Events Associated with the Use of Aspirin for Primary Prevention of Cardiovascular Disorders
- Role of Nanobiotechnology in Drug Discovery, Development and Molecular Diagnostic
- Therapeutic Uses of Aspirin
- Diabetes and Aspirin Resistance
- Pharmacogenetics and Pharmacogenomics Impact on Aspirin Response
- Risks Versus Benefits of Using Aspirin, Magnesium Sulfate, Corticosteroids, and Progesterone during Pregnancy
- Revisiting the Medicinal Value of Terpenes and Terpenoids